| 23275151 | PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells. | Carcinogenesis | 2013 Apr | Cheng H | doi: 10.1093/carcin/bgs393 |
| 22993403 | Dual roles of PARP-1 promote cancer growth and progression. | Cancer Discov | 2012 Dec | Schiewer MJ | doi: 10.1158/2159-8290.CD-12-0120 |
| 21612407 | Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. | DNA Cell Biol | 2011 Dec | Kim J | doi: 10.1089/dna.2011.1250 |
| 24939750 | Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription. | Oncotarget | 2014 Nov 15 | Ciccarone F | - |
| 28167507 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Clin Cancer Res | 2017 Jul 15 | Jiao S | doi: 10.1158/1078-0432.CCR-16-3215 |
| 29684820 | Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer. | Redox Biol | 2018 Jul | Hou D | doi: 10.1016/j.redox.2018.03.016 |
| 26920250 | Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer. | Biochem Pharmacol | 2016 May 1 | Zhou Q | doi: 10.1016/j.bcp.2016.02.015 |
| 29632181 | PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression. | Proc Natl Acad Sci U S A | 2018 Apr 24 | Drsam B | doi: 10.1073/pnas.1712345115 |
| 14557488 | Enhanced polyadenosine diphosphate-ribosylation in gonadotropin-releasing hormone agonist-treated uterine leiomyoma. | J Clin Endocrinol Metab | 2003 Oct | Huang SC | - |
| 24535833 | Inherited variation in the PARP1 gene and survival from melanoma. | Int J Cancer | 2014 Oct 1 | Davies JR | doi: 10.1002/ijc.28796 |
| 22472897 | PARP-1 protein expression in glioblastoma multiforme. | Eur J Histochem | 2012 Feb 27 | Galia A | doi: 10.4081/ejh.2012.e9. |
| 19655414 | The augmented anti-tumor effects of Antrodia camphorata co-fermented with Chinese medicinal herb in human hepatoma cells. | Am J Chin Med | 2009 | Li SL | - |
| 22864776 | Colorectal cancers differ in respect of PARP-1 protein expression. | Pol J Pathol | 2012 Jun | Sulzyc-Bielicka V | - |
| 25257171 | Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation. | Cell Death Differ | 2015 Feb | Kumari A | doi: 10.1038/cdd.2014.146 |
| 22392482 | Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ. | Apoptosis | 2012 Jul | Warrener P | doi: 10.1007/s10495-012-0707-4. |
| 18314489 | Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression. | Mol Cancer Res | 2008 Feb | Elser M | doi: 10.1158/1541-7786.MCR-07-0377. |
| 19784808 | Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. | Cell Mol Life Sci | 2009 Dec | Gopinath S | doi: 10.1007/s00018-009-0157-5 |
| 15286704 | Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair. | Oncogene | 2004 Sep 23 | Veuger SJ | - |
| 20113831 | Analysis of poly(ADP-ribose) polymerase-1 (PARP1) gene alteration in human germ cell tumor cell lines. | Cancer Genet Cytogenet | 2010 Feb | Ogino H | doi: 10.1016/j.cancergencyto.2009.10.012. |
| 21555554 | Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. | Proc Natl Acad Sci U S A | 2011 Jun 14 | Krawczyk PM | doi: 10.1073/pnas.1101053108 |
| 15564335 | The role of poly (adenosine 5'-diphosphate-ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species. | Endocrinology | 2005 Mar | Newton CJ | - |
| 27440880 | Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1. | J Virol | 2016 Sep 12 | Martin KA | doi: 10.1128/JVI.01180-16 |
| 27787517 | PARP1 regulates the protein stability and proapoptotic function of HIPK2. | Cell Death Dis | 2016 Oct 27 | Choi JR | doi: 10.1038/cddis.2016.345. |
| 28454547 | PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models. | Mol Cancer | 2017 Apr 28 | Pignochino Y | doi: 10.1186/s12943-017-0652-5. |
| 25225750 | PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer. | Genet Test Mol Biomarkers | 2014 Nov | Wang HT | doi: 10.1089/gtmb.2014.0106 |
| 23254695 | Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADPribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells. | Int J Oncol | 2013 Feb | Feng X | doi: 10.3892/ijo.2012.1740 |
| 22166496 | The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. | Carcinogenesis | 2012 Mar | Teo MT | doi: 10.1093/carcin/bgr300 |
| 24436031 | Expression of PARP-1 and its active polymer PAR in prostate cancer and benign prostatic hyperplasia in Chinese patients. | Int Urol Nephrol | 2014 Jul | Wu W | doi: 10.1007/s11255-014-0642-0 |
| 18716896 | PARP-1 Val762Ala polymorphism, CagA+ H. pylori infection and risk for gastric cancer in Han Chinese population. | Mol Biol Rep | 2009 Jul | Zhang Q | doi: 10.1007/s11033-008-9336-y |
| 22127734 | Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis. | Genet Epidemiol | 2012 Jan | Yu H | doi: 10.1002/gepi.20663 |
| 29393407 | PARP1-siRNA suppresses human prostate cancer cell growth and progression. | Oncol Rep | 2018 Apr | Lai Y | doi: 10.3892/or.2018.6238 |
| 24726141 | The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells. | Neoplasia | 2014 Mar | Piao L | doi: 10.1016/j.neo.2014.03.002 |
| 22221038 | PARP1 polymorphisms increase the risk of gastric cancer in a Chinese population. | Mol Diagn Ther | 2012 Feb 1 | He W | doi: 10.2165/11595630-000000000-00000. |
| 25037599 | PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines. | Hum Cell | 2014 Oct | Salemi M | doi: 10.1007/s13577-013-0076-5 |
| 20218899 | Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. | DNA Cell Biol | 2010 Jun | Wang M | doi: 10.1089/dna.2009.0969. |
| 23244082 | XRCC1 and ADPRT polymorphisms associated with survival in breast cancer cases treated with chemotherapy. | Asian Pac J Cancer Prev | 2012 | Ye S | - |
| 27871924 | MiR-335 regulates the chemo-radioresistance of small cell lung cancer cells by targeting PARP-1. | Gene | 2017 Feb 5 | Luo Y | doi: 10.1016/j.gene.2016.11.031 |
| 23510475 | Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity. | Cell Prolif | 2013 Apr | Loganathan R | doi: 10.1111/cpr.12014. |
| 19109787 | Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. | Methods Mol Biol | 2009 | Jiang J | doi: 10.1007/978-1-59745-416-2_16. |
| 22660976 | The role of PARP1 in the DNA damage response and its application in tumor therapy. | Front Med | 2012 Jun | Wang Z | doi: 10.1007/s11684-012-0197-3 |
| 22384823 | High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer. | Histopathology | 2012 Sep | Klauschen F | doi: 10.1111/j.1365-2559.2012.04225.x |
| 27466483 | Efficacy of the Combination of a PARP Inhibitor and UVC on Cancer Cells as Imaged by Focus Formation by the DNA Repair-related Protein 53BP1 Linked to Green Fluorescent Protein. | Anticancer Res | 2016 Aug | Tome Y | - |
| 25738796 | Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways. | Int J Mol Med | 2015 May | Zheng B | doi: 10.3892/ijmm.2015.2125 |
| 16328064 | Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis. | Oncol Rep | 2006 Jan | Zhai X | - |
| 20823142 | Poly (ADP-ribose) polymerase as a novel therapeutic target in cancer. | Clin Cancer Res | 2010 Sep 15 | Annunziata CM | doi: 10.1158/1078-0432.CCR-10-0526 |
| 23430444 | Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population. | Med Oncol | 2013 Jun | Li Y | doi: 10.1007/s12032-013-0505-z |
| 17560163 | Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients. | Mutat Res | 2007 Aug 15 | Cao WH | - |
| 24866151 | Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition. | Cancer Discov | 2014 Aug | Gonz??lez-Billalabeitia E | doi: 10.1158/2159-8290.CD-13-0230 |
| 27055253 | Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. | PLoS One | 2016 Apr 7 | Cardnell RJ | doi: 10.1371/journal.pone.0152584 |
| 24448423 | Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer. | Oncotarget | 2014 Jan 15 | Li D | - |
| 23644255 | Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1. | Gene | 2013 Jul 25 | Tang LY | doi: 10.1016/j.gene.2013.04.064 |
| 26826460 | Decreased DNA repair gene XRCC1 expression is associated with radiotherapy-induced acute side effects in breast cancer patients. | Gene | 2016 May 10 | Batar B | doi: 10.1016/j.gene.2016.01.040 |
| 23548269 | Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium. | Tumour Biol | 2016 Sep | Dimitrova D | - |
| 25128455 | Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer. | Eur J Cancer | 2014 Oct | Garc??a-Parra J | doi: 10.1016/j.ejca.2014.07.004 |
| 25883215 | Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity. | Oncotarget | 2015 May 10 | Frankum J | - |
| 23633189 | Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian women. | Mol Diagn Ther | 2013 Aug | Roszak A | doi: 10.1007/s40291-013-0036-5. |
| 26091341 | Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function. | Mol Cell | 2015 Jun 18 | Feng FY | doi: 10.1016/j.molcel.2015.04.016. |
| 21532888 | p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer. | Neoplasia | 2011 May | Meng F | - |
| 24535158 | Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph nodenegative early breast cancer: 15-year follow-up. | Oncol Rep | 2014 Apr | Donizy P | doi: 10.3892/or.2014.3024 |
| 25480692 | The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity. | Pathol Res Pract | 2015 Feb | Zhai L | doi: 10.1016/j.prp.2014.11.004 |
| 26540566 | Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications. | Oncotarget | 2015 Dec 29 | Park SH | doi: 10.18632/oncotarget.6264. |
| 25400754 | Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer. | Int J Clin Exp Pathol | 2014 Sep 15 | Kim HC | - |
| 19568233 | Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines. | Br J Cancer | 2009 Jul 21 | Zaremba T | doi: 10.1038/sj.bjc.6605166 |
| 25611238 | The prognostic and predictive significance of PARP-1 in locally advanced breast cancer of Egyptian patients receiving neoadjuvant chemotherapy. | Appl Immunohistochem Mol Morphol | 2015 Sep | Aiad HA | doi: 10.1097/PAI.0000000000000124. |
| 28118040 | PARP-1 Expression Quantified by [18F]FluorThanatrace: A Biomarker of Response to PARP Inhibition Adjuvant to Radiation Therapy. | Cancer Biother Radiopharm | 2017 Feb | Sander Effron S | doi: 10.1089/cbr.2016.2133 |
| 25333575 | Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress. | Oncol Rep | 2014 Dec | Jiang X | doi: 10.3892/or.2014.3533 |
| 17943227 | Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer. | J Hum Genet | 2007 | Durocher F | - |
| 25526641 | PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1. | PLoS One | 2014 Dec 19 | Dziaman T | doi: 10.1371/journal.pone.0115558 |
| 20373286 | Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibition. | EMBO Mol Med | 2010 Apr | Sourisseau T | doi: 10.1002/emmm.201000068. |
| 21434873 | Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers. | Biochem J | 2011 Jun 15 | Zaremba T | doi: 10.1042/BJ20101723. |
| 21037106 | Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. | Cancer Epidemiol Biomarkers Prev | 2010 Dec | Brevik A | doi: 10.1158/1055-9965.EPI-10-0606 |
| 22134241 | Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1. | Cell Cycle | 2011 Dec 15 | Vance S | doi: 10.4161/cc.10.24.18661 |
| 21908496 | Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. | Ann Oncol | 2012 May | Rojo F | doi: 10.1093/annonc/mdr361 |
| 17975135 | Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy. | Clin Cancer Res | 2007 Nov 1 | Plummer ER | - |
| 26356822 | Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer. | Oncotarget | 2015 Oct 13 | Brodie SA | doi: 10.18632/oncotarget.5040. |
| 23479135 | Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. | Cancer Chemother Pharmacol | 2013 May | Zhao W | doi: 10.1007/s00280-013-2127-8 |
| 24870775 | Novel mutations of the PARP-1 gene associated with colorectal cancer in the Saudi population. | Asian Pac J Cancer Prev | 2014 | Alshammari AH | - |
| 24489833 | Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies. | PLoS One | 2014 Jan 28 | Hua RX | doi: 10.1371/journal.pone.0087057 |
| 24761869 | Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy. | Asian Pac J Cancer Prev | 2014 | Xie KJ | - |
| 25528020 | Biological and clinical significance of PARP1 protein expression in breast cancer. | Breast Cancer Res Treat | 2015 Jan | Green AR | doi: 10.1007/s10549-014-3230-1 |
| 26387143 | Negative prognostic value of high levels of intracellular poly(ADP-ribose) in non-small cell lung cancer. | Ann Oncol | 2015 Dec | Michels J | doi: 10.1093/annonc/mdv393 |
| 22982218 | The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines. | Mol Cell Endocrinol | 2013 Jan 5 | Lavarone E | doi: 10.1016/j.mce.2012.08.019 |
| 27746584 | The Effect of Poly(ADP-ribose) Polymerase-1 Gene 3'Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort. | Dis Markers | 2016 | Alhadheq AM | - |
| 23317230 | Polymorphisms of XRCC1 and ADPRT genes and risk of noncardia gastric cancer in a Chinese population: a case-control study. | Asian Pac J Cancer Prev | 2012 | Pan XF | - |
| 21575865 | Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. | Cancer Cell | 2011 May 17 | Brenner JC | doi: 10.1016/j.ccr.2011.04.010. |
| 22337872 | CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation. | J Biol Chem | 2012 Apr 13 | Kashima L | doi: 10.1074/jbc.M111.321828 |
| 24853559 | PARP-1 Val762Ala polymorphism and risk of cancer: a meta-analysis based on 39 case-control studies. | PLoS One | 2014 May 22 | Qin Q | doi: 10.1371/journal.pone.0098022 |
| 27323894 | Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients. | Biomarkers | 2017 Feb | Nogueira A | doi: 10.1080/1354750X.2016.1204006 |
| 24889936 | Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancer. | J Pathol | 2014 Oct | Mart??nez-Bosch N | doi: 10.1002/path.4384 |
| 23803078 | The C allele of a synonymous SNP (rs1805414, Ala284Ala) in PARP1 is a risk factor for susceptibility to breast cancer in Saudi patients. | Asian Pac J Cancer Prev | 2013 | Alanazi M | - |
| 23073772 | Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis. | Mol Biol Rep | 2012 Dec | Pabalan N | doi: 10.1007/s11033-012-2009-x |
| 24191908 | BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer. | BMC Cancer | 2013 Nov 5 | Jacot W | doi: 10.1186/1471-2407-13-523. |
| 26900125 | Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. | Sci Rep | 2016 Feb 22 | Kossatz S | doi: 10.1038/srep21371. |
| 22983827 | Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population. | Mol Cell Biochem | 2013 Jan | Li K | doi: 10.1007/s11010-012-1442-4 |
| 19513550 | gammaH2AX and cleaved PARP-1 as apoptotic markers in irradiated breast cancer BT474 cellular spheroids. | Int J Oncol | 2009 Jul | Qvarnstrm OF | - |
| 27362900 | The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection. | Int J Gynecol Pathol | 2017 Mar | Hjortkjr M | doi: 10.1097/PGP.0000000000000310. |
| 28212434 | Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis. | PLoS One | 2017 Feb 17 | Qiao W | doi: 10.1371/journal.pone.0172413 |
| 27847302 | Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials. | Cancer Lett | 2017 Feb 1 | Yuan B | doi: 10.1016/j.canlet.2016.11.010 |
| 28302009 | Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement. | Curr Med Chem | 2017 | Mart??n-Guerrero SM | doi: 10.2174/0929867324666170316115039. |
| 28031413 | Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors. | Mol Cancer Res | 2017 Mar | Wielgos ME | doi: 10.1158/1541-7786.MCR-16-0287-T |
| 28985359 | PARP1 controls KLF4-mediated telomerase expression in stem cells and cancer cells. | Nucleic Acids Res | 2017 Oct 13 | Hsieh MH | doi: 10.1093/nar/gkx683. |
| 29063620 | Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance. | Prostate | 2017 Dec | Stark TW | doi: 10.1002/pros.23435 |
| 28713983 | MalforminA1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway. | Int J Oncol | 2017 Sep | Park SY | doi: 10.3892/ijo.2017.4070 |
| 28930534 | Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications. | Front Biosci (Landmark Ed) | 2018 Jan 1 | Piao L | - |
| 29048575 | MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. | Mutagenesis | 2017 Oct 17 | Schneiderova M | doi: 10.1093/mutage/gex026. |
| 28802254 | TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors. | Mol Cancer Ther | 2017 Nov | Al Abo M | doi: 10.1158/1535-7163.MCT-17-0110 |
| 30275188 | P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells. | Anticancer Res | 2018 Oct | Kim JY | doi: 10.21873/anticanres.12905. |
| 29973717 | CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. | Nature | 2018 Jul | Zimmermann M | doi: 10.1038/s41586-018-0291-z |
| 29950726 | High speed of fork progression induces DNA replication stress and genomic instability. | Nature | 2018 Jul | Maya-Mendoza A | doi: 10.1038/s41586-018-0261-5 |
| 24970803 | Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. | Oncotarget | 2014 Jul 15 | Bridges KA | - |
